Just five analysts cover the stock, according to FactSet data, but they have an average price target of $10.40, implying a ...

Both biotechs are a bit risky, but could benefit from clinical progress this year -- and the upside would be huge. CRISPR has ...

The global pharmaceutical industry will generate more than $1.2 trillion in sales in 2026, according to Statista. The oncology segment alone is expected to generate $232 billion in sales this year.

Shares of West Pharmaceutical Services Inc. shed 7.02% to $259.79 Friday, on what proved to be an all-around grim trading ...

The investment bank said many companies faced thesis-changing Phase 3 readouts this year, with outcomes that could materially reshape valuations regardless of the broader macro backdrop. But UBS also ...

Abivax ( ABVX +0.26%), a France-based biotech, saw its shares skyrocket by more than 1,740% last year after it made ...

As of Friday, January 09, Rigel Pharmaceuticals, Inc.’s RIGL share price has dipped by 5.01%, which has investors questioning ...

Recursion Pharmaceuticals has reported updated data from its ELUCIDATE & TUPELO trials, but the stock has failed to mount a ...

Welcome to the Sun Pharma Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock.

Samuel S Chowdhury, chairman of Square Pharmaceuticals PLC, has expressed his intention to purchase 20 lakh shares of the company at the prevailing market price through the Dhaka Stock Exchange (DSE).